Protiva Biotherapeutics

Developer of nucleic acid-based therapeutics to treat various diseases

placeVancouver, British Columbia, Canada calendar_todayFounded 2000 language protivabio.com

Innovation

69 patent families (31 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 12,343 times.

YearFilings
201328
201414
201521
201620
201718
201816
20195
20202
20211
20222
20231
20241

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon